Xue Hua
InvestorPhD at Propel Bio Partners
About
Xue Hua, PhD, has clinical research, operations, and regulatory experience in biotech. She previously served as Vice President of Clinical Development, Research at Athira Pharma (2015–2022), where she built the clinical team and led Fosgonimeton (ATH-1017) Phase I–III trials for Alzheimer's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Before industry, she was an assistant professor at the University of Southern California working on imaging technologies for neurological disorders, and she holds a PhD in Biomedical Engineering from UCLA.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Propel Bio Partners
Armaan Hirani
Data Science Associate at Propel Bio Partners
Carol Criner
Advisor at Propel Bio Partners
Dasom (Christine) Yoo
Senior Associate at Propel Bio Partners
Erik Gonzalez-Leon
Analyst at Propel Bio Partners
Jim Harding
Finance at Propel Bio Partners
Joyce Jiang
Analyst at Propel Bio Partners
Laurie Heilmann
Venture Partner at Propel Bio Partners
Leen Kawas
Managing General Partner at Propel Bio Partners
Frequently asked questions
- Who is Xue Hua?
- Xue Hua, PhD, has clinical research, operations, and regulatory experience in biotech. She previously served as Vice President of Clinical Development, Research at Athira Pharma (2015–2022), where she built the clinical team and led Fosgonimeton (ATH-1017) Phase I–III trials for Alzheimer's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Before industry, she was an assistant professor at the University of Southern California working on imaging technologies for neurological disorders, and she holds a PhD in Biomedical Engineering from UCLA.
- Where does Xue Hua work?
- Xue Hua is PhD at Propel Bio Partners.
- What does Xue Hua invest in?
- Xue Hua invests in Biotech.